Search results for: “astrazeneca”
-
AstraZeneca’s Truqap approved in US for advanced breast cancer
•
LONDON: AstraZeneca announced that its drug Truqap (capivasertib) has received approval from the US Food and Drug Administration…
-
AstraZeneca and Cellectis partner to accelerate development of next-generation therapeutics
•
LONDON, UK: AstraZeneca (NYSE: AZN) today announced a collaboration and investment agreement with Cellectis (NASDAQ: CLLS), a clinical-stage…
-
AstraZeneca settles Nexium and Prilosec product liability litigations
•
LONDON, UK: AstraZeneca has entered into settlement agreements in the product liability litigations related to Nexium and Prilosec.…
-
AstraZeneca prices a $2.25bn bond offering
•
LONDON, UK: AstraZeneca announced that its wholly owned subsidiary AstraZeneca Finance LLC, priced a three tranche global bond…
-
AstraZeneca agrees to acquire CinCor Pharma for upto $1.8 billion
•
LONDON, UK: AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma Inc., a US-based clinical-stage biopharmaceutical…
-
AstraZeneca agrees to acquire Neogene Therapeutics for up to $320 million
•
LONDON, UK: AstraZeneca announced an agreement to acquire Neogene Therapeutics Inc., for a total consideration of up to…
-
AstraZeneca to acquire TeneoTwo Inc for $100 million
•
LONDON, UK: AstraZeneca has signed agreement to acquire TeneoTwo Inc., including its Phase I clinical-stage CD19/CD3 T-cell engager,…
-
AstraZeneca setting up R&D centre in Cambridge, Massachusetts
•
LONDON: AstraZeneca has announced plans to open a new site at the heart of the Cambridge, MA, life sciences and innovation…
-
AstraZeneca signs multi-billion dollar deal with Ionis Pharmaceuticals
•
LONDON, UK: AstraZeneca has closed a global development and commercialisation agreement with Ionis Pharmaceuticals, Inc. (Ionis) for eplontersen, formerly known as…
-
AstraZeneca to transfer global rights for Eklira and Duaklir to Covis Pharma
•
LONDON, UK: AstraZeneca has agreed to transfer its global rights to Eklira (aclidinium bromide), known as Tudorza in the US, and Duaklir (aclidinium bromide/formoterol)…
-
AstraZeneca to fully acquire Caelum Biosciences
•
LONDON, UK: AstraZeneca‘s Alexion has exercised its option to acquire all remaining equity in Caelum Biosciences for CAEL-101,…
-
AstraZeneca plans $360 million Irish manufacturing investment
•
LONDON, UK: AstraZeneca is planning on establishing a next-generation active pharmaceutical ingredient (API) manufacturing facility for small molecules…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.